Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): Data from the BOLD Australia study

<b>Background:</b> Individuals with Preserved Ratio Impaired Spirometry (PRISm), defined as FEV<sub>1</sub>/FVC ≥0.7 and FEV1 <80% predicted, are at higher risk of developing COPD. However, data for Australian adults are limited. We aimed to describe prevalence of PRISm and its relationship with clinical characteristics in Australia. <b>Method:</b> Data from the Burden of Lung Disease (BOLD) Australia study of randomly selected adults aged ≥40 years from six sites was classified into airflow limitation, PRISm, or normal spirometry groups. Demographic, clinical characteristics, and lung function were compared between groups. <b>Results:</b> Of the study sample (<i>n</i> = 3518), 387 (11%) had PRISm, 549 (15.6%) had airflow limitation, and 2582 (73.4%) had normal spirometry. PRISm was more common in Indigenous Australian adults. Adults with PRISm had more frequent respiratory symptoms, more comorbidities, greater health burden and poorer quality of life than those with normal spirometry. Pre- and post-bronchodilator FEV<sub>1</sub> and FVC were lower in adults with PRISm than those with airflow limitation. Adults with PRISm were less likely to use respiratory medicine than those with airflow limitation (OR = 0.56, 95% CI 0.38-0.81). <b>Conclusions:</b> PRISm was present in 11% of adults in this study and they had similar respiratory symptoms and health burden as adults with airflow limitation.

Authors

Institutions

Publication Details

Journal
Chronic Respiratory Disease
Published
2025-01-22
DOI
https://doi.org/10.1177/14799731241312687
Citations
6
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
9.11

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): Data from the BOLD Australia study

Richard Wood‐Baker, Helen Kathryn Reddel, R Ampon, DP Johns et al.
6 citations
Chronic Respiratory Disease
Chronic Obstructive Pulmonary Disease (COPD) Research
9.11
article

Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): Data from the BOLD Australia study

Richard Wood‐Baker, Helen Kathryn Reddel, R Ampon, DP Johns, Guy B. Marks, Michael J. Abramson, Yijun Zhou, Anthony James, Graeme Maguire, Brett G. Toelle
article en
6 citations

Abstract

<b>Background:</b> Individuals with Preserved Ratio Impaired Spirometry (PRISm), defined as FEV<sub>1</sub>/FVC ≥0.7 and FEV1 <80% predicted, are at higher risk of developing COPD. However, data for Australian adults are limited. We aimed to describe prevalence of PRISm and its relationship with clinical characteristics in Australia. <b>Method:</b> Data from the Burden of Lung Disease (BOLD) Australia study of randomly selected adults aged ≥40 years from six sites was classified into airflow limitation, PRISm, or normal spirometry groups. Demographic, clinical characteristics, and lung function were compared between groups. <b>Results:</b> Of the study sample (<i>n</i> = 3518), 387 (11%) had PRISm, 549 (15.6%) had airflow limitation, and 2582 (73.4%) had normal spirometry. PRISm was more common in Indigenous Australian adults. Adults with PRISm had more frequent respiratory symptoms, more comorbidities, greater health burden and poorer quality of life than those with normal spirometry. Pre- and post-bronchodilator FEV<sub>1</sub> and FVC were lower in adults with PRISm than those with airflow limitation. Adults with PRISm were less likely to use respiratory medicine than those with airflow limitation (OR = 0.56, 95% CI 0.38-0.81). <b>Conclusions:</b> PRISm was present in 11% of adults in this study and they had similar respiratory symptoms and health burden as adults with airflow limitation.

Chronic Respiratory DiseaseVol. 22
The University of Sydney (AU), The University of Melbourne (AU), Curtin University (AU), Woolcock Institute of Medical Research (AU), Sir Charles Gairdner Hospital (AU), UNSW Sydney (AU), Sydney Local Health District (AU), South Western Sydney Local Health District (AU), Monash University (AU), Macquarie University (AU)
Pfizer, AstraZeneca, GlaxoSmithKline, Pfizer Australia, GlaxoSmithKline Australia, University of Tasmania, Charles Sturt University, Monash University, Medical Research Council, National Health and Medical Research Council
No poverty
Openalex Percentile: Top 2%
Chronic Obstructive Pulmonary Disease (COPD) Research
9.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.